Hereditary fructose intolerance (HFI) and essential fructosuria represent distinct pathophysiological outcomes within the domain of carbohydrate metabolism resulting from enzymatic deficiencies in the fructose catabolic pathway. HFI is defined by a deficiency in aldolase B, leading to toxic accumulation of fructose-1-phosphate, ATP depletion via futile phosphorylation cycles, and subsequent inhibitory effects on gluconeogenesis and glycogenolysis that precipitate hypoglycemia upon fructose ingestion. In contrast, essential fructosuria arises from a deficiency in fructokinase, causing benign hyperfructosemia without energy depletion or metabolic derangement. These concepts illustrate how specific enzymatic bottlenecks dictate the clinical severity of inherited metabolic disorders and define their therapeutic management through dietary restriction to prevent substrate accumulation.
Hereditary fructose intolerance (HFI) and essential fructosuria represent distinct pathophysiological outcomes within the domain of carbohydrate metabolism resulting from enzymatic deficiencies in th…